Jpan j clin oncol. 2009 39:244-250

Author: zmzw

August undefined, 2024

NettetJpn J Clin Oncol. 2009 Apr;39(4):260-6. doi: 10.1093/jjco/hyp006. Epub 2009 Mar 4. NettetInt J Radiat Oncol Biol Phys. 2002;52(2):283–293. 97. Dikken JL, Jansen EP, Cats A, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;28(14):2430–2436. 98.

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or ...

NettetAuthors now have the option to submit a graphical abstract or video abstract as part of the article, in addition to the text abstract. The graphical/video abstract should clearly … NettetJ Clin Oncol. 2009;27(20):3312–3318. 79. Hutson TE, Escudier B, Esteban E, et al. Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma. J Clin Oncol. 2014;32(8):760–767. 80. body\u0027s response to cold

The role of acoustofluidics and microbubble dynamics for …

Nettet2. sep. 2024 · J Clin Oncol 33(28):3124–3129 Article CAS PubMed Google Scholar Mizukami K, Iwasaki Y, Kawakami E et al (2024) Genetic characterization of pancreatic … Nettet10. apr. 2024 · Targeted drug delivery is proposed to reduce the toxic effects of conventional therapeutic methods. For that purpose, nanoparticles are loaded with drugs called nanocarriers and directed toward a s... Nettet1. okt. 2004 · Phase II Study of Cisplatin and 5-Fluorouracil with Concurrent Radiotherapy in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group Trial (JCOG9516) Kaoru Ishida, Nobutoshi Ando, Seiichiro Yamamoto, Hiroko Ide, Masayuki Shinoda body\u0027s resistance

randomized controlled Phase III trial comparing 2-weekly …

Phase I/II study of concurrent chemoradiotherapy for localized …

Nettet23. apr. 2024 · Deoxyribonucleic acid repair deficiency is emerging as a joint mechanism for breast cancer and reproductive aging. Recent studies showed that ovarian reserve may be lower in women with BRCA (g … Nettet1. des. 2009 · Purpose: Targeted therapy with the humanized monoclonal antibody trastuzumab has become a mainstay for human epidermal growth factor receptor 2 (HER2) -positive breast cancer (BC). The mechanisms of action of trastuzumab have not been fully elucidated, and data available to date are reviewed here. The impact of the … glitch digital agencyNettet20. nov. 2009 · Purpose: To explore a more effective treatment for localized nasal natural killer (NK)/T-cell lymphoma, we conducted a phase I/II study of concurrent chemoradiotherapy. Patients and methods: Treatments comprised concurrent radiotherapy (50 Gy) and 3 courses of dexamethasone, etoposide, ifosfamide, and carboplatin … body\\u0027s response to injury

"Nettet7. apr. 2024 · The TRANSFORMER study (NCT02286921) was a DOD-sponsored randomized phase II study designed to compare the efficacy of BAT vs. enzalutamide in asymptomatic men with CRPC progressing on abiraterone, Fig. 3. 39 The study was conducted in 195 patients who underwent 1:1 randomization to either standard dose … " - Jpan j clin oncol. 2009 39:244-250

Jpan j clin oncol. 2009 39:244-250

Comparison of single agent versus combined chemotherapy in …

NettetInt J Radiat Oncol Biol Phys. 2007;69(3):770–776. 21. Sun Q, Liu C, Zhong H, et al. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer. Jpn J Clin Oncol. 2009;39(4):237–243. 22. NettetThe second modulator, potassium oxonate (Oxo), localizing in mucosal cells of the gastrointestinal (GI) tract after oral administration, reduces the incidence of GI toxicities …

Did you know?

Nettet25. feb. 2010 · Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506 Japanese Journal of Clinical Oncology Oxford … NettetEpub 2009 May 30. Authors Takahisa Matsuda 1 , Takahiro Fujii , Yasushi Sano , Shin-ei Kudo , Yasushi Oda , Masahiro Igarashi , Hiroyasu Iishi , Yoshitaka Murakami , Hideki …

NettetA systematic review of the literature was conducted to clarify available knowledge on patient preferences regarding the communication of bad news and associated factors. … Nettet20. feb. 2024 · Thoracic Oncology Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, …

Nettet2. nov. 2015 · GI stromal tumor (GIST) is one of the most common single types of soft tissue sarcoma. 1 GIST usually arises from the GI tract and rarely, at other intra-abdominal sites. Approximately 60% of GISTs are cured with surgery, but metastases are frequent. 2 The malignancy potential of GIST varies greatly. 3,4 Several risk-stratification tools are … Nettet10. nov. 2008 · With a median follow-up of 109 months (range, 10 to 244), 170 (28%) developed transformation, 107 (63%) based on biopsy confirmation. The annual risk of transformation was 3% continuously through 15 years. A multivariate analysis of clinical factors at diagnosis identified advanced stage as the only predictor of future …

NettetInt J Clin Oncol. 2010;15(4):369–375. 32. Suyama T, Ueda T, Fukasawa S, et al. Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma. Jpn J Clin Oncol. 2009;39(4):244–250. 33. Srinivas S, Harshman LC. A phase II study of docetaxel and oxaliplatin for second-line treatment of urothelial ...

Nettet1. apr. 2013 · Because S-1 and GS have shown promising activity in PC, the present randomized phase III study (GEST [Gemcitabine and S-1 Trial] study) was designed to … glitch disc for saleNettet10. apr. 2024 · Since their first documentation in 1952, plaque reduction neutralization tests (PRNTs) have become the choice of test for the measurement of neutralizing antibodies against a particular virus. However, PRNTs can be performed only against viruses that cause cytopathic effects (CPE). PRNTs also require skilled personnel and … glitch dinheiro the crew 2NettetJ Clin Oncol. 2009;27(26):4247–4253. 10. Camidge DR, Kono SA, Flacco A, et al. Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment. Clin Cancer Res. 2010;16(22):5581–5590. 11. body\u0027s response to painNettetEmail [email protected]. Introduction: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are standard first-line treatments for advanced EGFR -mutated non-small-cell lung cancer (NSCLC) patients. The efficacy of EGFR-TKIs in older patients including poor Eastern Cooperative Oncology Group (ECOG) performance … body\u0027s response to stress pdfNettet5. apr. 2024 · 1 INTRODUCTION. Acute leukemia is infrequently diagnosed during pregnancy, although the true incidence rate is unknown [1-3].Based on previous reports published overseas in the 1980s, the incidence of such leukemia, both acute and chronic, was estimated to range from one in 75,000 to 100,000 pregnancies, [] while a more … body\\u0027s response to infectionNettet20. nov. 2009 · doi: 10.1200/jco.2009.23.1431 Abstract Purpose: Previous studies in non-small-cell lung cancer (NSCLC) have demonstrated a wide variation in responsiveness to epidermal growth factor receptor (EGFR) -targeting agents and in genetic aberrancies of the EGFR pathway according to ethnic background, most notably a higher frequency of … body\\u0027s response to stressNettet20. okt. 2016 · There were 1,370 patients (56%) with extraprostatic extension (EPE), 452 (18%) with seminal vesicle invasion (SVI), 1,434 (58%) with positive surgical margins, and 390 (16%) who received ADT (median, 6 months). The median pre-SRT PSA was 0.5 ng/mL (interquartile range, 0.3 to 1.1). glitch de v bucks fortnite